|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-4-2
|
|
pubmed:abstractText |
Two-thirds of patients with a gray-zone prostate-specific antigen (PSA) level undergo unnecessary biopsy. Sensitivity is not yet sufficient to permit the use of modified PSA parameters or magnetic resonance (MR) imaging alone for prostate cancer screening. Thus, we evaluated the combination of MR imaging and PSA density (PSAD) for specificity and sensitivity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1442-2042
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
322-6; discussion 327
|
|
pubmed:meshHeading |
pubmed-meshheading:18380820-Adult,
pubmed-meshheading:18380820-Aged,
pubmed-meshheading:18380820-Aged, 80 and over,
pubmed-meshheading:18380820-Biopsy,
pubmed-meshheading:18380820-Humans,
pubmed-meshheading:18380820-Magnetic Resonance Imaging,
pubmed-meshheading:18380820-Male,
pubmed-meshheading:18380820-Middle Aged,
pubmed-meshheading:18380820-Prostate,
pubmed-meshheading:18380820-Prostate-Specific Antigen,
pubmed-meshheading:18380820-Prostatic Neoplasms,
pubmed-meshheading:18380820-Sensitivity and Specificity
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
|
|
pubmed:affiliation |
Department of Urology, Gifu University School of Medicine, Gifu, Japan. kubomitu@zj8.so-net.ne.jp
|
|
pubmed:publicationType |
Journal Article
|
